Jonathan Alicea

A pediatric dermatologist discusses dupilumab for pediatric atopic dermatitis in addition to promising new therapies.

A uveitis specialist breaks down what occurs during the uveitis-dedicated event and comments on its importance.

Raymond Douglas, MD, PhD discusses how the COVID-19 pandemic has affected his clinical practice and potentially accelerated technological innovation as a whole.

A post-hoc analysis of the CANTREAT trial finds similar GA frequency, characteristics, and surface area between patients in treat-and-extend and once-monthly regimen cohorts.

A recent study presented at AAO 2020 reports that increased choroid vascular flow was noted in both small and large vessels in patients with non-vitrectomized eyes.

A new study from AAO 2020 is the first to show a significant association between peripapillary vessel density loss and progression of diabetic retinopathy.

A new IRIS registry analysis reports that many patients with geographic atrophy do not continue follow-up after initial visit or consultation.

Geeta Lalchandani-Lalwani, MD discusses the importance of early DR detection as well as findings from her study that suggest a need for more personalized therapies.

For patients with ETDRS DRSS scores of 47-53, about 40% experienced 2-step DR worsening by year 5.

Lynn Hassman, MD, talks about a promising new technology that can optimize precision medicine in patients with uveitis.

The study presented at AAO provides an update on previously shared 6-month data from earlier this year.

Raymond Douglas, MD, PhD, discusses data that demonstrate the benefit of teprotumumab in patients with all levels of thyroid eye disease.

Edmund Tsui, MD, talks the new AAO 2020 virtual format as well as presentations that have particularly caught his attention.

SimpleSENSE is a first-of-its-kind cloth-based diagnostic platform that can capture more than 100 million data points per patient per day across cardiac, pulmonary, and circulatory biomarkers.

Identifying early stages of chronic kidney disease in patients with sickle cell anemia has the potential of allowing for personalized treatment and better prognosis.

A greater number of cumulative days of montelukast use did not increase the risk of ADHD in these patients.

Lisa Swanson, MD, and Brad Glick, DO, FAAD, discuss a wide range of dermatological conditions faced by pediatric patients—from acne to atopic dermatitis, and everything in between.

ContagionLive releases their latest e-book on this year's flu season, which includes expert-led opinions and interviews.

Investigators evaluate 35-year height and BMI trajectories for 200 countries and 65 million participants.

In new data presented at ACG 2020, investigators report on the clinical characteristics and outcomes of chronic pancreatitis patients with CDI.

The Norfolk Diabetes Prevention Study is the largest type 2 diabetes prevention trial since the US Diabetes Prevention Program more than 20 years ago.

A new study finds patients with sickle cell disease are moderately adherent to hydroxyurea.

The label now indicates hydroxyurea use does not affect benefit received from the medication.

Investigators conducted an educational intervention aimed at strengthening healthcare providers’ readiness to address issues related to medication adherence.

Up to 91% of the gastroenterologist respondents plan to integrate telehealth into their practice following the COVID-19 pandemic.

Skin pigmentation disorders do not always have a cure or treatment, and they may cause social or emotional burdens for the patient.

A new ACG study shows that 18% would have been considered low risk for NASH-F based on FAST score despite having high liver stiffness measurement.

Girish Hiremath, MD, MPH, discusses a need to more accurately and objectively assess pediatric compliance to eosinophilic esophagitis therapies.

The CDC has standardized guidelines to help diagnose diarrhea, a potential indicator of c. difficile infection.

Benjamin Noor, MD, discusses a recent study from ACG that demonstrated that EBTs are associated with improved parameters for weight loss and diabetes.